ArticleAmerican journal of hematology2020

A multi-institutional comparison of mitoxantrone, etoposide, and cytarabine vs high-dose cytarabine and mitoxantrone therapy for patients with relapsed or refractory acute myeloid leukemia.

Sonia Christian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.